Compare Flux Power Holdings Inc (FLUX) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs GSK plc — how do they compare? Flux Power Holdings Inc trades at $0.6 (market cap $11.23M), while GSK plc trades at $50.33 (market cap $102.60B). The key difference: GSK plc is far larger — about 9136.2× Flux Power Holdings Inc's market cap, and GSK plc pays a 3.57% dividend while Flux Power Holdings Inc pays none. Which is the better fit depends on your goals.
| FLUX | GSK | |
|---|---|---|
Market Cap | $11.23M | $102.60B |
Sector | Utilities | Health |
52-Week High | $6.66 | $61.18 |
52-Week Low | $0.51 | $38.22 |
Enterprise Value | $17.39M | $123.04B |
Dividend Yield | — | 3.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX stock surged 17.58% to $0.6161, showing strong daily momentum despite a bearish technical backdrop with 17 sell signals. The company reported mixed quarterly earnings, missing estimates in Q3 2025 and Q1 2026 but beating in Q4 2025. Revenue declined to $51M in 2026 from $66M in 2025, with a net income margin of -12.48%. Recent developments include the launch of SkyEMS 3.0 AI platform and a new VP of Sales appointment, aiming to bolster growth in the energy storage sector.
Outlook is cautiously optimistic due to unanimous analyst buy ratings but tempered by profitability challenges and technical weakness. Key opportunities lie in AI-driven fleet solutions expansion, while risks include persistent losses, competitive pressure, and execution hurdles in scaling operations.
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
